-
1
-
-
0037392540
-
Analgesic, antipyretic and anti-inflammatory effect of essential oil of Lippia multiflora
-
Abena A.A., Diatewa M., Gakosso G., Gbeassor M., Hondi-Assah T., and Ouamba J.M. Analgesic, antipyretic and anti-inflammatory effect of essential oil of Lippia multiflora. Fitoterapia 74 (2003) 231-236
-
(2003)
Fitoterapia
, vol.74
, pp. 231-236
-
-
Abena, A.A.1
Diatewa, M.2
Gakosso, G.3
Gbeassor, M.4
Hondi-Assah, T.5
Ouamba, J.M.6
-
2
-
-
0037484758
-
-
Agence de Coopération Culturelle et Technique, première édition (ACCT), Paris
-
Adjanohoun E.J., Ahyi M.R.A., Ake Assi L., Akpagana K., Chibon P., El-Haji A., Eyme J., Garba M., Gassita J.-N., Gbeassor M., Goudote E., Guinko S., Hodouto K.-K., Houngnon P., Keita A., Keoula Y., Kluga-Ocloo W.P., Lo I., Siamevi K.M., and Taffame K.K. Contribution aux études ethnobotaniques et floristiques au Togo. first ed. (1986), Agence de Coopération Culturelle et Technique, première édition (ACCT), Paris
-
(1986)
Contribution aux études ethnobotaniques et floristiques au Togo. first ed.
-
-
Adjanohoun, E.J.1
Ahyi, M.R.A.2
Ake Assi, L.3
Akpagana, K.4
Chibon, P.5
El-Haji, A.6
Eyme, J.7
Garba, M.8
Gassita, J.-N.9
Gbeassor, M.10
Goudote, E.11
Guinko, S.12
Hodouto, K.-K.13
Houngnon, P.14
Keita, A.15
Keoula, Y.16
Kluga-Ocloo, W.P.17
Lo, I.18
Siamevi, K.M.19
Taffame, K.K.20
more..
-
3
-
-
33748565005
-
a-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus
-
Ali H., Houghton P.J., and Soumyanath A. a-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. Journal of Ethnopharmacology 107 (2006) 449-455
-
(2006)
Journal of Ethnopharmacology
, vol.107
, pp. 449-455
-
-
Ali, H.1
Houghton, P.J.2
Soumyanath, A.3
-
6
-
-
0034181895
-
Use of herbal remedies by patients in a health maintenance organization
-
Bennett J., and Brown C.M. Use of herbal remedies by patients in a health maintenance organization. Journal of American Pharmacists Association 40 (2000) 353-358
-
(2000)
Journal of American Pharmacists Association
, vol.40
, pp. 353-358
-
-
Bennett, J.1
Brown, C.M.2
-
9
-
-
0036587593
-
Effect of several Chinese natural health products of human cytochrome P450 metabolism
-
Foster B.C., Vandenhoek S., Li K.Y., Tang R., Budzinski J.W., and Krantis A. Effect of several Chinese natural health products of human cytochrome P450 metabolism. Journal of Pharmacology and Pharmaceutical Science 5 (2002) 185-189
-
(2002)
Journal of Pharmacology and Pharmaceutical Science
, vol.5
, pp. 185-189
-
-
Foster, B.C.1
Vandenhoek, S.2
Li, K.Y.3
Tang, R.4
Budzinski, J.W.5
Krantis, A.6
-
10
-
-
0037911509
-
In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products
-
Foster B.C., Vandenhoek S., Hana J., Krantis A., Akhtar M.H., Bryan M., Budzinski J.W., Ramputh A., and Arnason J.T. In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 10 (2003) 334-342
-
(2003)
Phytomedicine
, vol.10
, pp. 334-342
-
-
Foster, B.C.1
Vandenhoek, S.2
Hana, J.3
Krantis, A.4
Akhtar, M.H.5
Bryan, M.6
Budzinski, J.W.7
Ramputh, A.8
Arnason, J.T.9
-
12
-
-
0346656878
-
Rapid determination of enzyme activities of recombinant human cytochrome P450, Human liver microsomes and hepatocytes
-
Ghosal A., Hapangama N., Yuan Y., Lu X., Horne D., Patrick J.E., and Zbaida S. Rapid determination of enzyme activities of recombinant human cytochrome P450, Human liver microsomes and hepatocytes. Biopharmaceutics & Drug Disposition 24 (2003) 375-384
-
(2003)
Biopharmaceutics & Drug Disposition
, vol.24
, pp. 375-384
-
-
Ghosal, A.1
Hapangama, N.2
Yuan, Y.3
Lu, X.4
Horne, D.5
Patrick, J.E.6
Zbaida, S.7
-
13
-
-
1942497956
-
Cytochrome P450, drugs, and diseases
-
Guengerich F.P. Cytochrome P450, drugs, and diseases. Molecular Interventions 3 (2003) 194-204
-
(2003)
Molecular Interventions
, vol.3
, pp. 194-204
-
-
Guengerich, F.P.1
-
14
-
-
9144237410
-
Drugs interactions with herbal products and grapefruit juice: a conference report
-
Huang S.-M., Hall S.D., Watkins P., Love L.A., Erabjt-Singh C., Betz J.M., Hoffman F.A., Honig P., Coates P.M., Bull J., Chen S.T., Kearns G.L., and Murray M.D. Drugs interactions with herbal products and grapefruit juice: a conference report. Clinical Pharmacology & Therapeutics 75 (2004) 1-11
-
(2004)
Clinical Pharmacology & Therapeutics
, vol.75
, pp. 1-11
-
-
Huang, S.-M.1
Hall, S.D.2
Watkins, P.3
Love, L.A.4
Erabjt-Singh, C.5
Betz, J.M.6
Hoffman, F.A.7
Honig, P.8
Coates, P.M.9
Bull, J.10
Chen, S.T.11
Kearns, G.L.12
Murray, M.D.13
-
15
-
-
0035071598
-
Sequence diversity of CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
-
Kuehl P., Zhang J., Lin Y., Lamba J., Assem M., Schetz J., Watkins P.B., Daly A., Wrighton S.A., Hall S.D., Maurel P., Relling M., Brimer C., Yasuda K., Venkataramanan R., Strom S., Thummel K., Boguski M.S., and Schuetz E. Sequence diversity of CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nature Genetics 27 (2001) 383-391
-
(2001)
Nature Genetics
, vol.27
, pp. 383-391
-
-
Kuehl, P.1
Zhang, J.2
Lin, Y.3
Lamba, J.4
Assem, M.5
Schetz, J.6
Watkins, P.B.7
Daly, A.8
Wrighton, S.A.9
Hall, S.D.10
Maurel, P.11
Relling, M.12
Brimer, C.13
Yasuda, K.14
Venkataramanan, R.15
Strom, S.16
Thummel, K.17
Boguski, M.S.18
Schuetz, E.19
-
16
-
-
33845953716
-
A new CYP3A5 variant, CYP3A5*11, Is Shown to Be Defective in nifedipine metabolism in a recombinant cDNA expression system
-
Lee S.-J., van der Heiden I.P., Goldstein J.A., and van Schaik R.H.N. A new CYP3A5 variant, CYP3A5*11, Is Shown to Be Defective in nifedipine metabolism in a recombinant cDNA expression system. Drug Metabolism and Disposition 35 (2007) 67-71
-
(2007)
Drug Metabolism and Disposition
, vol.35
, pp. 67-71
-
-
Lee, S.-J.1
van der Heiden, I.P.2
Goldstein, J.A.3
van Schaik, R.H.N.4
-
17
-
-
22944448354
-
Variability of CYP3A7 expression in human fetal liver
-
Leeder J.S., Gaedigk R., Marcucci K.A., Gaedigk A., Vyhlidal C.A., Schindel B.P., and Pearce R.E. Variability of CYP3A7 expression in human fetal liver. The Journal of Pharmacology and Experimental Therapeutics 314 (2005) 626-635
-
(2005)
The Journal of Pharmacology and Experimental Therapeutics
, vol.314
, pp. 626-635
-
-
Leeder, J.S.1
Gaedigk, R.2
Marcucci, K.A.3
Gaedigk, A.4
Vyhlidal, C.A.5
Schindel, B.P.6
Pearce, R.E.7
-
18
-
-
4744365529
-
CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjects
-
Min D.I., Ellingrod V.L., Marsh S., and Mcleod H. CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjects. Therapeutic Drug Monitoring 26 (2004) 524-528
-
(2004)
Therapeutic Drug Monitoring
, vol.26
, pp. 524-528
-
-
Min, D.I.1
Ellingrod, V.L.2
Marsh, S.3
Mcleod, H.4
-
19
-
-
0242276321
-
CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids
-
Nakamura H., Torimoto N., Ishii I., Ariyoshi N., Nakasa H., Ohmori S., and Kitada M. CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids. Drug Metabolism and Disposition 31 (2003) 432-438
-
(2003)
Drug Metabolism and Disposition
, vol.31
, pp. 432-438
-
-
Nakamura, H.1
Torimoto, N.2
Ishii, I.3
Ariyoshi, N.4
Nakasa, H.5
Ohmori, S.6
Kitada, M.7
-
20
-
-
21844435507
-
Opposite effects of short-term and long-term St. John wort intake on voriconazole pharmacokinetics
-
Rengelshausen J., Banfield M., Riedel K.-D., Burhenne J., Weiss J., Thomsen T., Walter-Sack H.W.E., and Mikus G. Opposite effects of short-term and long-term St. John wort intake on voriconazole pharmacokinetics. Clinical Pharmacology & Therapeutics 78 (2005) 25-33
-
(2005)
Clinical Pharmacology & Therapeutics
, vol.78
, pp. 25-33
-
-
Rengelshausen, J.1
Banfield, M.2
Riedel, K.-D.3
Burhenne, J.4
Weiss, J.5
Thomsen, T.6
Walter-Sack, H.W.E.7
Mikus, G.8
-
21
-
-
22344450724
-
CYP3A5 genetic polymorphisms in different ethnic populations
-
Roy J.-N., Lajoie J., Zijenah L.S., Barama A., Poirier C., Ward B.J., and Roger M. CYP3A5 genetic polymorphisms in different ethnic populations. Drug Metabolism and Disposition 33 (2005) 884-887
-
(2005)
Drug Metabolism and Disposition
, vol.33
, pp. 884-887
-
-
Roy, J.-N.1
Lajoie, J.2
Zijenah, L.S.3
Barama, A.4
Poirier, C.5
Ward, B.J.6
Roger, M.7
-
22
-
-
0030696487
-
Mechanism of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins
-
Schmiedlin-Ren P., Edwards D.J., Fitzsimmons M.E., He K., Lown K.S., Woster P.M., Rahman A., Thummel K.E., Fisher J.M., Hollenberg P.F., and Watkins P.B. Mechanism of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metabolism and Disposition 25 (1997) 1228-1233
-
(1997)
Drug Metabolism and Disposition
, vol.25
, pp. 1228-1233
-
-
Schmiedlin-Ren, P.1
Edwards, D.J.2
Fitzsimmons, M.E.3
He, K.4
Lown, K.S.5
Woster, P.M.6
Rahman, A.7
Thummel, K.E.8
Fisher, J.M.9
Hollenberg, P.F.10
Watkins, P.B.11
-
23
-
-
6344285930
-
Genetic variation in eleven phases I drug metabolism genes in an ethnically diverse population
-
Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q., McMunn C., Ihrie P., Mehall J.M., Edwards T.L., and Dawson E.P. Genetic variation in eleven phases I drug metabolism genes in an ethnically diverse population. Pharmacogenomics 5 (2004) 895-931
-
(2004)
Pharmacogenomics
, vol.5
, pp. 895-931
-
-
Solus, J.F.1
Arietta, B.J.2
Harris, J.R.3
Sexton, D.P.4
Steward, J.Q.5
McMunn, C.6
Ihrie, P.7
Mehall, J.M.8
Edwards, T.L.9
Dawson, E.P.10
-
25
-
-
0037518214
-
Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism
-
Westlind-Johnsson A., Malmebo S., Johnsson A., Otter C., Andersson T.B., Johansson I., Edwards I.J., Boobis A.R., and Ingelman-Sunberg M. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metabolism and Disposition 31 (2003) 755-761
-
(2003)
Drug Metabolism and Disposition
, vol.31
, pp. 755-761
-
-
Westlind-Johnsson, A.1
Malmebo, S.2
Johnsson, A.3
Otter, C.4
Andersson, T.B.5
Johansson, I.6
Edwards, I.J.7
Boobis, A.R.8
Ingelman-Sunberg, M.9
-
26
-
-
0036320872
-
Comparative metabolic capabilities of CYP3A4, CYP3A5 and CYP3A7
-
Williams J.A., Ring B.J., Cantrell V.E., Jones D.R., Eckstein J., Ruterbories K., Hamman M.A., Hall S.D., and Wrighton S.A. Comparative metabolic capabilities of CYP3A4, CYP3A5 and CYP3A7. Drug Metabolism and Disposition 30 (2002) 883-891
-
(2002)
Drug Metabolism and Disposition
, vol.30
, pp. 883-891
-
-
Williams, J.A.1
Ring, B.J.2
Cantrell, V.E.3
Jones, D.R.4
Eckstein, J.5
Ruterbories, K.6
Hamman, M.A.7
Hall, S.D.8
Wrighton, S.A.9
-
27
-
-
16244368066
-
Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers
-
Yamaori S., Yamazaki H., Iwano S., Kiyotani K., Matsumura K., Saito T., Parkinson A., Nakagawa K., and Kamataki T. Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers. Xenobiotica 35 (2005) 69-83
-
(2005)
Xenobiotica
, vol.35
, pp. 69-83
-
-
Yamaori, S.1
Yamazaki, H.2
Iwano, S.3
Kiyotani, K.4
Matsumura, K.5
Saito, T.6
Parkinson, A.7
Nakagawa, K.8
Kamataki, T.9
-
28
-
-
0031944723
-
Overlapping substrate specificities of cytochrome P450 and P-glycoprotein for novel cysteine protease inhibitor
-
Zhang Y., Guo X., Lin E.T., and Benet L.Z. Overlapping substrate specificities of cytochrome P450 and P-glycoprotein for novel cysteine protease inhibitor. Drug Metabolism and Disposition 26 (1998) 360-366
-
(1998)
Drug Metabolism and Disposition
, vol.26
, pp. 360-366
-
-
Zhang, Y.1
Guo, X.2
Lin, E.T.3
Benet, L.Z.4
|